|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 November 2012 |
|
Main ID: |
NCT00946816 |
|
Date of registration:
|
20/07/2009 |
|
Primary sponsor: |
|
|
Public title:
|
The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
|
|
Scientific title:
|
The Effects of Dietary Intervention on Gastrointestinal Motility, Hormonal Feedback, Visceral Sensation and Satiety in Patients With Anorexia Nervosa and Obesity |
|
Date of first enrolment:
|
September 2010 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00946816 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Michael Fried, Professor MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospital Zurich, Gastroenterology and Hepatology |
| | |
|
Key inclusion & exclusion criteria
|
In addition to satisfying specific DSMIV criteria for anorexia nervosa (B1, B2) or WHO criteria for obesity (C1), or obesity and diabetes mellitus type II (C2), general inclusion criteria include:
- aged at least 18 and not more than 40 years
- able to communicate well with the investigators and provide written consent
- no physical co-morbidity requiring active treatment, in particular diabetes mellitus, impairment of liver or kidney function (subjects with diabetes mellitus type II are eligible for study group C2)
- no psychiatric (DSM IV) disorders limiting the ability to comply with study requirements
- no use of medications influencing upper GI motility within one week of the study (i.e. nitrates, prokinetic drugs, macrolide antibiotics). Acid suppression and antihypertensive medication beta-blocker, calcium channel blockers are acceptable.
- no evidence of current drug or alcohol abuse
- no history of gastrointestinal disease or surgery except appendicectomy or hernia repair
- females will take a urine pregnancy test before each study, any participant with a positive pregnancy test will be excluded (females will be investigated always in the same menstrual phase)
Exclusion criteria:
• pregnancy
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Anorexia Nervosa
|
|
Healthy Participants
|
|
Obesity
|
|
Intervention(s)
|
|
Behavioral: Nutritional Intervention
|
|
Primary Outcome(s)
|
|
The GI response to a given meal in terms of: motility, neurohormonal feedback, sensation and satiety
[Time Frame: 2 years]
|
|
Secondary ID(s)
|
|
SNF 320030_1253331
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|